For the NRP2 pathway, positive score of 4 and 6 were obtained for the DFS and OS of ccRCC patients, − 8 and − 2 scores for M1 ccRCC patients and − 5 and − 7 scores for the PFS and OS of TNBC patients. This evidence concerns the gene NRP2 and nonpapillary renal cell carcinoma.